MLR 1019Alternative Names: MLR-1019
Latest Information Update: 16 Jul 2016
Price : $50
At a glance
- Originator Melior Discovery
- Developer Melior Pharmaceuticals, Inc.
- Class Antiparkinsonians; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Psychiatric disorders
- No development reported Parkinson's disease